| Hans-Günter Meyer-Thompson | Fachveröffentlichungen
American College of Medical Toxicology and the American Academy of Clinical Toxicology position statement: nalmefene should not replace naloxone as the primary opioid antidote at this time.
American College of Medical Toxicology and the American Academy of Clinical Toxicology position statement: nalmefene should not replace naloxone as the primary opioid antidote at this time.
Stolbach, A. I., Mazer-Amirshahi, M. E., Nelson, L. S., & Cole, J. B. (2023).
Clinical Toxicology, 61(11), 952–955. https://doi.org/10.1080/15563650.2023.2283391
Abstract
https://www.tandfonline.com/doi/full/10.1080/15563650.2023.2283391